A state-of-the-art review released today aims to explore the overlaps between influenza and COVID-19, their implications for cardiovascular disease, and strategies for vaccine development.
Viral respiratory infections are known to raise the risk of acute CV events and, despite evidence supporting a flu shot as a means to improve outcomes, many barriers to vaccination still exist. Even at-risk patients often fail to get their shot annually.
SARS-CoV-2, the virus behind the pandemic, arrives on this backdrop. The new review, in part, addresses whether lessons from influenza can be applied to COVID-19 given the many cardiovascular ramifications of the disease and proposes that studies now taking place could be redeployed to glean insights into COVID-19.
Already, several international CV outcome trials are investigating whether seasonal influenza vaccine reduces the risk of cardiovascular events among patients with heart failure or coronary artery disease, the documents authors point out. Existing trial networks may provide an opportunity to assess primary and secondary prevention strategies for patients with CVD at risk of complications from COVID-19.
Jacob A. Udell, MD, MPH (University of Toronto, Canada), the reports senior author, told TCTMD that the idea for this review emerged as he and others were wrapping up INVESTED, a US National Institutes of Health-funded RCT of the flu vaccine for cardioprotection. Together, they joined up with researchers from two other randomized trials in this areaIAMI and IVVEto compile a review specific to influenza.
As we were doing that, of course, COVID hits, said Udell. Since then research has moved at warp speed to better understand an illness that he described as on steroids, a super cold virus, with a wide net of clinical manifestations.
Current COVID-19 vaccine trials are not only enrolling mostly younger adults but also focused mainly on preventing infection, Udell continued. Yes, of course, breaking the chain of COVID infection would be great. But knowing when we can take the masks off? I think many people are going to want to know whether these vaccines are preventing complicated COVID infections: pneumonia, hospitalization, ventilation, death.
Whats Known, Whats Not
The review, with Bahar Behrouzi, MSc, and Maria Viviana Araujo Campoverde, BSc (both University of Toronto), as lead authors, attempts to capture this swiftly evolving field. Published online in the Journal of the American College of Cardiology, it starts out with a recap of whats known about the links between influenza and CVD as well as whats swiftly being learned about the novel coronavirus, its interaction with cardiovascular risk factors, and its ability to inflict cardiovascular damage.
Influenza viruses, they note, have proinflammatory and prothrombotic effects that increase the risks of acute MI and heart failure. When patients already have CVD, flu infection is more likely to cause fever, tachycardia, potential volume overload, and arrhythmias. That picture has substantial overlap with COVID-19, the authors note. Here, there are also proinflammatory and prothrombotic effects and the common sequelaeare acute MI, myocardial injury, heart failure, disseminated thrombosis, hypotension, arrhythmia, sudden cardiac death, and pediatric inflammatory multisystem syndrome.
The review also addresses vaccination strategies in both settings, the role of inflammation, and whats known about the cardioprotective effects of flu shots and whats currently recommended by health authorities. As the authors note, the World Health Organization, the US Centers for Disease Control and Prevention, and the European Centre for Disease Prevention and Control all have slightly different recommendations, which the document addresses.
Finally, Behrouzi et al summarize the ongoing trials both in the setting of influenza and CVD as well as COVID-19 and efforts to redeploy cardiovascular outcome trials related to influenza to SARS-CoV-2.
Building Better Vaccines
Udell pointed out that as the aforementioned CV outcomes trials wrap up, there will be an existing infrastructure for vaccine research. We have networks across the world of cardiologists who have been vaccinating people with heart disease for the last few years who are probably in a really good position to test COVID vaccines in high-risks patients, as well, he said, adding, No ones necessarily knocking on our door, and were not necessarily looking for business, but we thought, just in case society thinks this is important, we should probably [put this out there].
Since the 1918 pandemic resulting from the H1N1 virus, vaccines have been made the same way: chicken eggs. We literally have farms of eggs, like out of a dystopian movie, for . . . harvesting shots, Udell explained. They inject the eggs with the antigens of the viruses we think are going to be coming around. We grow these antigens in eggs, and then we harvest these antigens. We mass produce them and clean them and thats what you end up getting in your arm.
Now, 100 years later, it turns out viruses arent so dumb, he said. Were seeing that our vaccines are starting to have a waning response against the H1N1 and H3N2 strains, both of avian origins, as the viruses adapt.
Indeed, over the course of their review, investigators came upon what Udell described as a dirty little secret about influenza vaccinesthe efficacy of flu shots appears to have the lowest efficacy in the highest-risk patients. During the 2018-2019 flu season, effectiveness in patients 65 and older was approximately 20% against H1N1 and H3N2, the authors note. Those diminishing returns, he continued, have been a little bit disappointing, to be honest. And that data is out there, but I dont think anyone has really put it together.
There are various reasons why this might be the case, he suggested. One is that older adults and people with comorbidities dont have as strong of an immune response to vaccines, lessening their effectiveness. And even if this can be overcome, theres the question whether an effective vaccine can improve CV outcomes.
Thats a big concern. We need to fix that, Udell said. The RNA-based techniques being used for COVID-19 vaccine development, though more expensive than the egg approach, may in turn allow for a mass production of a flu vaccine made the same way, he said, noting that this could be the one silver lining out of a terrible situation.
I think many people are going to want to know whether these vaccines are preventing complicated COVID infections: pneumonia, hospitalization, ventilation, death. Jacob A. Udell
Udell advised that, even with the influenza vaccines limitations, clinicians should still encourage their patients to get their shot.
Let us not overthink this, he said. Were disappointed it isnt like the polio vaccine and it isnt 100% effective, granted. Its still better than nothing, so 20% effectiveness of reducing your chances of flu, let alone the translation to a hard outcome of pneumonia or cardiovascular complications or deathIll take that, especially for high-risk individuals.
When it comes to flu shots, there should be no hesitation on the side of the healthcare professional, Udell stressed.
More:
Understanding How Flu Viruses Affect the Heart Could Boost COVID-19 Care - TCTMD
- Best 30 Cardiology in Secaucus, NJ with Reviews - YP.com - April 12th, 2018 [April 12th, 2018]
- Cardiology | Weill Cornell Medicine - April 14th, 2018 [April 14th, 2018]
- Cardiology Conferences 2018 | Cardiology Meetings 2018 ... - April 26th, 2018 [April 26th, 2018]
- Dr. Anil Goel, MD - Birmingham, MI - Cardiology & Clinical ... - April 26th, 2018 [April 26th, 2018]
- Clinical Physiology (Cardiology) MSc/PGDip | Middlesex ... - May 15th, 2018 [May 15th, 2018]
- Cardiology Conferences 2018 | Upcoming Cardiology ... - May 16th, 2018 [May 16th, 2018]
- Clinical Cardiology Section | Cleveland Clinic - May 27th, 2018 [May 27th, 2018]
- Journal of Clinical and Experimental Cardiology - Open ... - June 6th, 2018 [June 6th, 2018]
- Cardiology Summit 2018 | Cardiology Conferences | Heart ... - June 23rd, 2018 [June 23rd, 2018]
- Cardiology Clinical and Research Faculty Members ... - June 26th, 2018 [June 26th, 2018]
- Cardiology Conferences 2018 | Cardiology Congress 2018 ... - June 26th, 2018 [June 26th, 2018]
- About Us - New Jersey Cardiology Associates - July 8th, 2018 [July 8th, 2018]
- About Us - Ventura Clinical Trials - August 16th, 2018 [August 16th, 2018]
- Clinical Cardiology Made Ridiculously Simple: Michael A ... - August 22nd, 2018 [August 22nd, 2018]
- Clinical Cardiology - American Society of Preventive Cardiology - October 2nd, 2018 [October 2nd, 2018]
- Heart Surgery Hospital in india | Cardiology Treatment ... - October 7th, 2018 [October 7th, 2018]
- Clinical Cardiology - American Society of Preventive ... - December 3rd, 2018 [December 3rd, 2018]
- Guideline Clinical App - American College of Cardiology - December 7th, 2018 [December 7th, 2018]
- Journal of Clinical and Experimental Cardiology- Open ... - December 12th, 2018 [December 12th, 2018]
- Clinical Cardiology - Baptist Health - December 30th, 2018 [December 30th, 2018]
- Cardiology at Cancun: Topics in Clinical Cardiology - February 5th, 2019 [February 5th, 2019]
- Department of Cardiovascular Medicine, KU School of Medicine - March 10th, 2019 [March 10th, 2019]
- Towards Health Equality: Improving the Management of Cardiovascular Diseases in Women - International Atomic Energy Agency - September 21st, 2019 [September 21st, 2019]
- Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors - TCTMD - September 21st, 2019 [September 21st, 2019]
- DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF - TCTMD - September 21st, 2019 [September 21st, 2019]
- Combining Nature and Technology, Luye Medical and Cleveland Clinic Join to Build a Future Hospital in Shanghai - Yahoo Finance - September 21st, 2019 [September 21st, 2019]
- Will Renal Denervation for Hypertension Rise Again? - Medscape - September 21st, 2019 [September 21st, 2019]
- Obstructive Sleep Apnea, Sleep Symptoms, and their Association with Cardiovascular Disease - DocWire News - September 21st, 2019 [September 21st, 2019]
- CNE expands pulmonary, sleep services with Brigham & Women's physicians - Warwick Beacon - September 21st, 2019 [September 21st, 2019]
- What I Am Most Looking Forward to at TCT 2019 - TCTMD - September 21st, 2019 [September 21st, 2019]
- Serelaxin Not Linked to CV Mortality Reduction in Patients Hospitalized for Acute HF - The Cardiology Advisor - September 21st, 2019 [September 21st, 2019]
- Sacubitril-Valsartan Not Linked to Lower Hospitalization Risk, CV Death in HFpEF - The Cardiology Advisor - September 21st, 2019 [September 21st, 2019]
- FDA clears multiuse angiography systems from Siemens Healthineers - DOTmed HealthCare Business News - September 21st, 2019 [September 21st, 2019]
- Balloon Pulmonary Angioplasty Effective for Chronic Thromboembolic PH - The Cardiology Advisor - September 21st, 2019 [September 21st, 2019]
- RWJBarnabas Health, St. Luke's University Health launch clinical affiliation - FierceHealthcare - September 21st, 2019 [September 21st, 2019]
- Bilirubin: A Novel Indicator of Infective Endocarditis Adverse Outcomes - The Cardiology Advisor - September 21st, 2019 [September 21st, 2019]
- Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS - TCTMD - September 21st, 2019 [September 21st, 2019]
- Community-based Care Model Reduces CVD Risk - Managed Healthcare Executive - September 21st, 2019 [September 21st, 2019]
- American College of Cardiology Steps Up: Equal Pay, Opportunities for All - TCTMD - September 21st, 2019 [September 21st, 2019]
- FDA Approves Novo Nordisk's Oral Semaglutide, First GLP-1 in Pill Form - AJMC.com Managed Markets Network - September 21st, 2019 [September 21st, 2019]
- A New Drug for HF? DEFINE-HF Bolsters Dapagliflozin Cardio Cred - Medscape - September 21st, 2019 [September 21st, 2019]
- Seeking Synergy: Bringing Cardiology into Your Enterprise Imaging Strategy - Health Imaging - September 21st, 2019 [September 21st, 2019]
- TCT 2019 Day Two: Transcatheter Valves, New and Old - TCTMD - September 30th, 2019 [September 30th, 2019]
- Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis - TCTMD - September 30th, 2019 [September 30th, 2019]
- Bypass Surgery and Coronary Stenting Yield Comparable 10-Year Survival - Diagnostic and Interventional Cardiology - September 30th, 2019 [September 30th, 2019]
- TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 - TCTMD - September 30th, 2019 [September 30th, 2019]
- Eidos Therapeutics to Present Interim Analysis of the Ongoing Phase 2 Open-Label Extension Study of AG10 in Patients with TTR Amyloid Cardiomyopathy... - September 30th, 2019 [September 30th, 2019]
- Off Script: The New Gatekeepers of Procedural Education - TCTMD - September 30th, 2019 [September 30th, 2019]
- Study Shows Safety and Efficacy of Near Infrared Spectroscopy (NIRS) Imaging to Identify Patients and Plaques at an Increased Risk for MACE - BioSpace - September 30th, 2019 [September 30th, 2019]
- The Heart of the Matter: Cardiovascular Fitness in Horses - United States Eventing Association - September 30th, 2019 [September 30th, 2019]
- Google parent Alphabet hires former FDA head Robert Califf to lead health strategy and policy - FierceHealthcare - September 30th, 2019 [September 30th, 2019]
- Inclisiran Benefits Patients With Familial Hypercholesterolemia and ASCVD - The Cardiology Advisor - September 30th, 2019 [September 30th, 2019]
- AUGUSTUS: Best Benefit With Apixaban, P2Y12 Inhibitor Dual Therapy - Medscape - September 30th, 2019 [September 30th, 2019]
- New TAVR System Safe and Effective for High-Risk Surgical Patients with Severe Aortic Stenosis - Newswise - September 30th, 2019 [September 30th, 2019]
- Dapagliflozin Improves Heart Failure-Related Health Status in HFrEF - The Cardiology Advisor - September 30th, 2019 [September 30th, 2019]
- Remote Ischemic Conditioning Did Not Improve 12 Month Clinical Outcomes After STEMI - The Cardiology Advisor - September 30th, 2019 [September 30th, 2019]
- Insights from the European Society of Cardiology congress | Speaking of Medicine - PLoS Blogs - September 30th, 2019 [September 30th, 2019]
- Smokers Have More Pulmonary Emboli, Leading to Higher Hospital Readmission Rates | - Diagnostic and Interventional Cardiology - October 22nd, 2019 [October 22nd, 2019]
- AZ's Farxiga gets heart failure prevention okay from FDA - PMLiVE - October 22nd, 2019 [October 22nd, 2019]
- Bayer Announces Recipients of the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards at CHEST Annual Meeting 2019 - BioSpace - October 22nd, 2019 [October 22nd, 2019]
- The Epidemic Of The Metabolic Syndrome Among The Palestinians In The G | DMSO - Dove Medical Press - October 22nd, 2019 [October 22nd, 2019]
- Optina Diagnostics and the Montreal Heart Institute Partner to Develop a New Biomarker for Atherosclerosis - PRNewswire - October 22nd, 2019 [October 22nd, 2019]
- Even With Same Diagnosis, Women Get Half the Heart Attack Treatments as Men - AJMC.com Managed Markets Network - October 22nd, 2019 [October 22nd, 2019]
- Eva Dickerman, Andrew Weil - The New York Times - October 22nd, 2019 [October 22nd, 2019]
- EHR vendor Veradigm and partners creating new shared data tools for researchers - Healthcare IT News - October 22nd, 2019 [October 22nd, 2019]
- Evolocumab Well-tolerated as Add-on for Hypercholesterolemia Therapy - DocWire News - October 22nd, 2019 [October 22nd, 2019]
- Deborah Heart and Lung Center announces affiliation with Cleveland Clinic Heart & Vascular Institute - Health Essentials from Cleveland Clinic - October 22nd, 2019 [October 22nd, 2019]
- New Registry to Provide Insight into STEMI Occurrence, Treatment in North India | - Diagnostic and Interventional Cardiology - October 22nd, 2019 [October 22nd, 2019]
- Finding Your Best Fit in Cardiology - TCTMD - October 22nd, 2019 [October 22nd, 2019]
- Cardiology team expands to meet community need - The Union of Grass Valley - October 22nd, 2019 [October 22nd, 2019]
- Deaths After Ablation of Atrial Fibrillation 'Concerning' in Real-World Analysis - TCTMD - November 1st, 2019 [November 1st, 2019]
- Cutler Family gifts $15 million to University Hospitals to transform mens health care - Newswise - November 1st, 2019 [November 1st, 2019]
- Troponin Increases After Elective PCI Tied to Complexity, Extent of CAD - TCTMD - November 1st, 2019 [November 1st, 2019]
- Caregiving and the Soul of Medicine - Medscape - November 1st, 2019 [November 1st, 2019]
- STEMI Mortality Unaffected by Weekend, Weeknight, or Holiday Admission in France - TCTMD - November 1st, 2019 [November 1st, 2019]
- Cardiva Medical publishes positive results from the AMBULATE pivotal study Cardiology2.0 - Cardiology2.0 - November 1st, 2019 [November 1st, 2019]
- Gaps in Access to TAVR and SAVR: 'Something Needs to Be Done' - TCTMD - November 1st, 2019 [November 1st, 2019]
- Cardiva Medical Announces Publication of Data From the AMBULATE Pivotal Study in the Journal of the American College of Cardiology: Clinical... - November 1st, 2019 [November 1st, 2019]
- Raymond James 4 Analyst Favorite Health Care Picks With Huge Upside Potential - 24/7 Wall St. - November 7th, 2019 [November 7th, 2019]
- Global Computed Tomography (CT) Scanners Devices and Equipment Market Report 2020: Major Players are GE Healthcare, Koninklijke Philips, Hitachi,... - November 7th, 2019 [November 7th, 2019]